glp-1 intestinal paralysis legal team in louisiana LSU Health Digital Scholar Ozempic GLP-1 Lawsuit & Gastroparesis

Studies are currently examining the role of GLP-1s in conditions such as heart failure with preserved ejection fraction, metabolic dysfunction-associated steatohepatitis, Alzheimers disease, Parkinsons disease, peripheral artery disease, diabetic kidney disease and cancer, and other pharmaceutical manufacturers are expected to apply for similar GLP-1 label expansions in the future

A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Overdosing is a risk

Support for Mobility and Joint Health Losing weight helps decrease pressure on joints, which improves mobility and physical comfort

A number of telehealth companies now offer the option to access these medications without ever leaving your home

Cardiovascular Endocrinology & Metabolism